What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Gene
His primary scientific interests are in Internal medicine, Primary biliary cirrhosis, Gastroenterology, Surgery and Immunology.
His research integrates issues of Placebo and Endocrinology in his study of Internal medicine.
He has included themes like Cohort, Pathology, Cirrhosis, Biliary cirrhosis and Transplantation in his Primary biliary cirrhosis study.
His Gastroenterology research includes themes of Fatty liver, Liver transplantation, Obeticholic acid and Hepatitis.
Within one scientific family, David Jones focuses on topics pertaining to Severity of illness under Surgery, and may sometimes address concerns connected to Quality of life.
His study focuses on the intersection of Immunology and fields such as Genotype with connections in the field of Human leukocyte antigen.
His most cited work include:
- EASL Clinical Practice Guidelines: management of cholestatic liver diseases (1033 citations)
- A Placebo-controlled trial of obeticholic acid in primary biliary cholangitis (461 citations)
- Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis (372 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Primary biliary cirrhosis, Gastroenterology, Immunology and Endocrinology.
His Internal medicine research is multidisciplinary, incorporating perspectives in Surgery and Cardiology.
His study in Primary biliary cirrhosis is interdisciplinary in nature, drawing from both Quality of life, Biliary cirrhosis, Disease, Pathology and Liver disease.
David Jones works in the field of Gastroenterology, namely Cholestasis.
His Immunology study focuses mostly on Antigen and Immune system.
He most often published in these fields:
- Internal medicine (27.71%)
- Primary biliary cirrhosis (16.02%)
- Gastroenterology (12.22%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (27.71%)
- Gastroenterology (12.22%)
- Ursodeoxycholic acid (3.48%)
In recent papers he was focusing on the following fields of study:
Internal medicine, Gastroenterology, Ursodeoxycholic acid, Hepatology and Primary are his primary areas of study.
His research is interdisciplinary, bridging the disciplines of Placebo and Internal medicine.
As part of the same scientific family, David Jones usually focuses on Gastroenterology, concentrating on Primary sclerosing cholangitis and intersecting with Autoimmune hepatitis.
His work deals with themes such as Agonist and Alkaline phosphatase, which intersect with Ursodeoxycholic acid.
His studies deal with areas such as Cirrhosis and Cholestasis as well as Obeticholic acid.
His research on Primary biliary cirrhosis frequently links to adjacent areas such as Liver disease.
Between 2015 and 2021, his most popular works were:
- A Placebo-controlled trial of obeticholic acid in primary biliary cholangitis (461 citations)
- EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis (370 citations)
- The UK-PBC risk scores: Derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis (156 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Gene
His primary areas of study are Internal medicine, Gastroenterology, Ursodeoxycholic acid, Hepatology and Adverse effect.
His research in Internal medicine tackles topics such as Surgery which are related to areas like Alkaline phosphatase.
His Gastroenterology research integrates issues from Placebo, Randomized controlled trial, Bile acid and Primary sclerosing cholangitis.
His Ursodeoxycholic acid study combines topics from a wide range of disciplines, such as Cholestasis, Clinical endpoint, Obeticholic acid, Disease and Alanine transaminase.
In his study, Pharmacotherapy, Drug development and Nonalcoholic fatty liver disease is inextricably linked to Liver disease, which falls within the broad field of Hepatology.
His work focuses on many connections between Adverse effect and other disciplines, such as Pharmacokinetics, that overlap with his field of interest in CXCL10, Liver function tests and Chemokine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
